Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Hemingway

Showing results (171-180 of 245) with videos related to

Pageof 25
Sort By:
European Heart Journal|March 23, 2017
Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivorsLaura Pasea, Sheng-Chia Chung, Mar Pujades-Rodriguez, et al.
BMJ (Clinical Research Ed.)|February 7, 2013
Prognosis research strategy (PROGRESS) 4: stratified medicine researchAroon D Hingorani, Daniëlle A van der Windt, Richard D Riley, et al.
Cardiovascular Research|July 28, 2019
Statistics on mortality following acute myocardial infarction in 842 897 EuropeansOras A Alabas, Tomas Jernberg, Mar Pujades-Rodriguez, et al.
European Journal of Preventive Cardiology|March 10, 2023
Determining cardiovascular risk in patients with unattributed chest pain in UK primary care: an electronic health record studyKelvin P Jordan, Trishna Rathod-Mistry, Danielle A van der Windt, et al.
Plos Medicine|February 9, 2013
Prognosis Research Strategy (PROGRESS) 2: prognostic factor researchRichard D Riley, Jill A Hayden, Ewout W Steyerberg, et al.
Clinical Medicine (London, England)|December 4, 2021
'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV)Amitava Banerjee, Laura Pasea, Sinduja Manohar, et al.
Kidney International|June 20, 2022
A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney diseaseAshkan Dashtban, Mehrdad A Mizani, Spiros Denaxas, et al.
Journal of the American College of Cardiology|June 3, 2017
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular DysfunctionTatendashe B Dondo, Marlous Hall, Robert M West, et al.
European Journal of Heart Failure|December 30, 2021
A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potentialAmitava Banerjee, Laura Pasea, Sheng-Chia Chung, et al.
Lancet (London, England)|June 3, 2014
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million peopleEleni Rapsomaniki, Adam Timmis, Julie George, et al.
Pageof 25

Showing results (171-180 of 245) with videos related to

Sort By:
Pageof 25
European Heart Journal|March 23, 2017
Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivorsLaura Pasea, Sheng-Chia Chung, Mar Pujades-Rodriguez, et al.
BMJ (Clinical Research Ed.)|February 7, 2013
Prognosis research strategy (PROGRESS) 4: stratified medicine researchAroon D Hingorani, Daniëlle A van der Windt, Richard D Riley, et al.
Cardiovascular Research|July 28, 2019
Statistics on mortality following acute myocardial infarction in 842 897 EuropeansOras A Alabas, Tomas Jernberg, Mar Pujades-Rodriguez, et al.
European Journal of Preventive Cardiology|March 10, 2023
Determining cardiovascular risk in patients with unattributed chest pain in UK primary care: an electronic health record studyKelvin P Jordan, Trishna Rathod-Mistry, Danielle A van der Windt, et al.
Plos Medicine|February 9, 2013
Prognosis Research Strategy (PROGRESS) 2: prognostic factor researchRichard D Riley, Jill A Hayden, Ewout W Steyerberg, et al.
Clinical Medicine (London, England)|December 4, 2021
'What is the risk to me from COVID-19?': Public involvement in providing mortality risk information for people with 'high-risk' conditions for COVID-19 (OurRisk.CoV)Amitava Banerjee, Laura Pasea, Sinduja Manohar, et al.
Kidney International|June 20, 2022
A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney diseaseAshkan Dashtban, Mehrdad A Mizani, Spiros Denaxas, et al.
Journal of the American College of Cardiology|June 3, 2017
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular DysfunctionTatendashe B Dondo, Marlous Hall, Robert M West, et al.
European Journal of Heart Failure|December 30, 2021
A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potentialAmitava Banerjee, Laura Pasea, Sheng-Chia Chung, et al.
Lancet (London, England)|June 3, 2014
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million peopleEleni Rapsomaniki, Adam Timmis, Julie George, et al.
Pageof 25